Data collection

Rapid reviews

Adaptation of cost effectiveness models

Adaptation of budget impact models

Full dossier development

Submission critique

Expertise and a safe pair of hands are a prerequisite for undertaking and sustaining your reimbursement pathway. AXIS has over seven years of experience in economic modelling and HTA dossier development for agencies such as the National Centre for Pharmacoeconomics, Scottish Medicines Consortium and All Wales Medicines Strategy Group.

“The AXIS team supported us throughout the entire submission process including development of our Rapid Review dossier, full HTA & Pricing Negotiations which all led to a successful reimbursement outcome in Ireland. The team’s expertise and experience of NCPE submissions ensured that our HTA was of an exceptionally high standard and importantly, was delivered on time.”

Paul Byrne, General Manager
Ipsen Pharmaceuticals Ltd., March 2019

“We commissioned AXIS Healthcare Consulting to assist us in the preparation for a full HTA on one of our medicines. We required a variety of Irish specific data points for our submission. The team at AXIS demonstrated meticulous attention to detail in sourcing and verifying the data required.”

Associate Market Access Director,
BMS, Ireland